Polar Asset Management Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Polar Asset Management Partners’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,000	Closed	-$409K	–	901
2024 Q2	$409K	Sell	10,000 -15,000	-60%	-$625K	0.01%	435
2024 Q1	$1.06M	Sell	25,000 -15,000	-38%	-$630K	0.02%	434
2023 Q4	$1.7M	Sell	40,000 -7,400	-16%	-$213K	0.03%	386
2023 Q3	$1.03M	Buy	+47,400	New	+$1.19M	0.02%	457

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Polar Asset Management Partners's CERE Position: Q3 2024 in Review

Polar Asset Management Partners sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 10,000 shares — an estimated $409K sold.

Polar Asset Management Partners first reported a position in CERE in Q3 2023 and held it in 4 quarters. The position peaked at $1.7M in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Polar Asset Management Partners reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Polar Asset Management Partners sold 10,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $409K.
Polar Asset Management Partners first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
Polar Asset Management Partners's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.7M in Q4 2023.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Polar Asset Management Partners's 13F filing for Q3 2024, filed 14 Nov 2024.